What’s new: Some local governments across China, now including Beijing, have issued policies aimed at boosting the biopharmaceutical industry, including more financing support for innovative drugmakers, as the industry endures a prolonged capital winter.
On Sunday, the capital’s authorities announced measures to support the development of innovative drugs, including efforts to improve the quality and efficiency of clinical studies on such drugs and accelerate their approval.
